1. Lieberman DA; AGA CRC Workshop Panel. Commentary: liquid biopsy for average-risk colorectal cancer screening. Clin Gastroenterol Hepatol. 2024;22(6):1160-1164.
2. Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977.
3. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281.
4. Cologuard Plus™ Clinician Brochure. Madison, WI: Exact Sciences Corporation.
5. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-1297.
6. Cologuard^® Clinician Brochure. Madison, WI: Exact Sciences Corporation.
7. Healthcare Effectiveness Data and Information Set (HEDIS^®) Measurement Year 2025: Measures and Descriptions. National Committee for Quality Assurance. August 2024. Accessed July 29, 2025. https://wpcdn.ncqa.org/www-prod/wp-content/uploads/HEDIS-MY-2025-Measure-Description.pdf
8. Data on file for coverage. Market Access. 2025. Exact Sciences Corporation. Madison, WI.
9. CMS. FAQs about Affordable Care Act implementation part 51, Families First Coronavirus Response Act and Coronavirus Aid, Relief, and Economic Security Act implementation. Centers for Medicare & Medicaid Services. January 10, 2022. Accessed July 29, 2025. https://www.cms.gov/CCIIO/Resources/Fact-Sheets-and-FAQs/Downloads/FAQs-Part-51.pdf
10. CMS. Calendar year (CY) 2023 Medicare physician fee schedule final rule. Centers for Medicare & Medicaid Services. November 1, 2022. Accessed July 29, 2025. https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2023-medicare-physician-fee-schedule-final-rule
11. Insurance coverage for colorectal cancer screening. American Cancer Society. Updated February 27, 2025. Accessed July 29, 2025. https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/screening-coverage-laws.html
12. Shield™ Provider Brochure. Redwood City, CA: Guardant Health, 2024.
13. Kisiel JB, Fendrick AM, Ebner DW, et al. Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening. J Med Econ. 2024;27(1):746-753.
14. Bresalier RS, Grady WM, Markowitz SD, et al. Biomarkers for early detection of colorectal cancer: the early detection research network, a framework for clinical translation. Cancer Epidemiol Biomarkers Prev. 2020;29(12):2431-2440.

© 2025 Exact Sciences Corporation. All rights reserved.